"It has a good track record and earnings seem to be growing at 35%-40% even in depressed time so it has moved away from being a concept sto...

"If I were to look at what is happening we all know that Reliance is stuck in an EPS range between 62 to 68 and I would guess that with the...

"The earnings trajectory for Sun Pharma looks good. So any dip is a buying opportunity. "

L&T have already reported close to 17,000 odd crore of order inflows which means 20,000 crore expectation is going to be met.

The round of commentary from most of the guys is seemingly negative on IT sector, says Anish Damania, Emkay Global

We should see somewhere around 115 or 120 kind of a price range for this stock, says Anish Damania, Emkay Global Financial Services Ltd.

Titan reported very good numbers and were significantly ahead of estimates.

Grasim is looking good. They have also recently hiked their prices, despite the fact that we are seeing some softening of the cotton prices.

If you look at this is a first rally where the banking sector has underperformed the broad index Nifty. It is for the first time when this ...

The stock has corrected significantly over the last one or two months and this is also a good time to look at BPCL as well as the oil story...

Now pharma is a main buzz word. So anything which has pharma behind its name or any of its activity that is pharma besides its name the sto...

For these companies to get substantially re-rated on a longer timeframe, then it will require the clarity in the regulatory mechanism to re...

"We have been negative on SBI and have no reason to look at it again now. We will have a relook at it about 15% lower from here."

There may not be any rerating but one could follow the earnings growth of the pharma pack.

I think that is not a very large portion of their total assets what we feel is that given the fact that the stock has run up quite a lot.

Pharma is going to remain expensive or you would find it relatively expensive because a) it has growth, b) it has cash flow and c) it has g...

I think we have to stop talking about where the Nifty could be because action is so stock specific.